{"id":21130,"date":"2026-06-25T11:40:45","date_gmt":"2026-06-25T14:40:45","guid":{"rendered":"https:\/\/acrisure.com.br\/insights\/?p=21130"},"modified":"2026-06-25T11:46:45","modified_gmt":"2026-06-25T14:46:45","slug":"ozivy-aprovacao-anvisa","status":"publish","type":"post","link":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/","title":{"rendered":"Ozivy: Anvisa aprova semaglutida nacional para tratamento do diabetes"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Post&#8221; _builder_version=&#8221;4.19.4&#8243; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;Post&#8221; _builder_version=&#8221;4.19.4&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;Conte\u00fado&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; text_letter_spacing=&#8221;1px&#8221; custom_margin=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span data-contrast=\"auto\">O cen\u00e1rio de sa\u00fade no Brasil tem apresentado crescimento de condi\u00e7\u00f5es cr\u00f4nicas relacionadas ao diabetes. Dados do Minist\u00e9rio da Sa\u00fade mostram que o percentual de\u00a0<\/span><a href=\"https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2026\/janeiro\/diabetes-cresce-135-no-brasil-em-18-anos-hipertensao-e-obesidade-tambem-avancam-saude-lanca-viva-mais-brasil-com-r-340-mi-para-a-promocao-da-saude\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">adultos com diagn\u00f3stico da doen\u00e7a passou de 5,5% para 12,9%<\/span><\/a><span data-contrast=\"auto\"> entre 2006 e 2024.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Com o aumento da preval\u00eancia da doen\u00e7a, a amplia\u00e7\u00e3o das op\u00e7\u00f5es terap\u00eauticas ganha cada vez mais relev\u00e2ncia para pacientes, operadoras e sistemas de sa\u00fade. Nesse movimento, <strong>a Anvisa aprovou a\u00a0Ozivy<\/strong>, alternativa nacional an\u00e1loga ao Ozempic para tratamento de adultos com diabetes tipo 2.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><em>Leia tamb\u00e9m:\u00a0<\/em><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"-\" data-font=\"Aptos\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Aptos&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;-&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><a href=\"https:\/\/acrisure.com.br\/insights\/estudo-aponta-avanco-da-obesidade\/\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">Estudo aponta avan\u00e7o acelerado da obesidade na sa\u00fade suplementar e pressiona setor<\/span><\/a><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"-\" data-font=\"Aptos\" data-listid=\"2\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Aptos&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;-&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><a href=\"https:\/\/acrisure.com.br\/insights\/analise-preditiva-otimiza-custos\/\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">Como a An\u00e1lise Preditiva otimiza custos e bem-estar nas empresas<\/span><\/a><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/li>\n<\/ul>\n<h2 aria-level=\"2\"><span data-contrast=\"none\">Ozivy: medicamento possui mesmo princ\u00edpio ativo do Ozempic<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:160,&quot;335559739&quot;:80,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">A\u00a0Ozivy\u00a0\u00e9 um medicamento \u00e0 base a semaglutida, mesmo princ\u00edpio ativo do Ozempic, com efeito agonistas do receptor de GLP-1.\u00a0<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Conforme aprova\u00e7\u00e3o regulat\u00f3ria, ele est\u00e1 restrito para o tratamento de\u00a0<\/span><b><span data-contrast=\"auto\">adultos com diabetes tipo 2<\/span><\/b><span data-contrast=\"auto\">\u00a0<\/span><b><span data-contrast=\"auto\">que n\u00e3o apresentam controle adequado dos n\u00edveis de glicose<\/span><\/b><span data-contrast=\"auto\">, como complemento \u00e0 dieta e \u00e0 pr\u00e1tica de exerc\u00edcios f\u00edsicos, nas seguintes situa\u00e7\u00f5es:<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\u00b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\u00b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><b><span data-contrast=\"auto\">Em monoterapia<\/span><\/b><span data-contrast=\"auto\">;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559737&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:276,&quot;335559991&quot;:360}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\u00b7\" data-font=\"Symbol\" data-listid=\"1\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\u00b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><b><span data-contrast=\"auto\">Em associa\u00e7\u00e3o a outros medicamentos<\/span><\/b><span data-contrast=\"auto\">\u00a0para o tratamento do diabetes.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559737&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276,&quot;335559991&quot;:360}\">\u00a0<\/span><\/li>\n<\/ul>\n<h3 aria-level=\"3\"><span data-contrast=\"none\">Administra\u00e7\u00e3o e prescri\u00e7\u00e3o<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:160,&quot;335559739&quot;:80,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h3>\n<p><span data-contrast=\"auto\">O produto \u00e9 apresentado na forma de solu\u00e7\u00e3o injet\u00e1vel em caneta preenchida para administra\u00e7\u00e3o semanal. E como todos os medicamentos do tipo GLP-1, a semaglutida sint\u00e9tica est\u00e1 sujeita \u00e0 prescri\u00e7\u00e3o de receita m\u00e9dica em duas vias.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span data-contrast=\"none\">O avan\u00e7o das canetas emagrecedoras e o aumento da aten\u00e7\u00e3o sobre uso e indica\u00e7\u00e3o<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;201341983&quot;:0,&quot;335559738&quot;:160,&quot;335559739&quot;:80,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">Nos \u00faltimos anos, medicamentos \u00e0 base de semaglutida ganharam visibilidade fora do ambiente estritamente cl\u00ednico, impulsionados pela populariza\u00e7\u00e3o das chamadas\u00a0<\/span><b><span data-contrast=\"auto\">canetas emagrecedoras<\/span><\/b><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Esse movimento ampliou o interesse p\u00fablico e aumentou a aten\u00e7\u00e3o de operadoras e reguladores sobre o uso adequado dessas terapias, j\u00e1 que diferentes medicamentos da mesma classe podem ter indica\u00e7\u00f5es distintas.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<h2><span data-contrast=\"none\">O impacto das canetas emagrecedoras na sa\u00fade suplementar e nos custos corporativos<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/h2>\n<p><span data-contrast=\"auto\">A press\u00e3o sobre custos m\u00e9dicos segue entre as principais preocupa\u00e7\u00f5es na sa\u00fade suplementar, e a entrada de novas terapias, como as canetas emagrecedoras, amplia essas discuss\u00f5es.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Segundo o Relat\u00f3rio Global sobre Sa\u00fade Corporativa 2026, 65% das empresas indicam o crescimento do uso desses medicamentos como um dos fatores que podem impactar os custos de sa\u00fade nos pr\u00f3ximos anos.<\/span><span data-ccp-props=\"{&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Nesse cen\u00e1rio, a aprova\u00e7\u00e3o da\u00a0Ozivy\u00a0pela Anvisa aumenta a concorr\u00eancia entre medicamentos da mesma classe, estimula ofertas mais competitivas em termos de custo-benef\u00edcio e amplia o potencial de acesso ao tratamento do diabetes e suas comorbidades.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Anvisa aprovou a Ozivy, semaglutida nacional para tratamento do diabetes tipo 2. O avan\u00e7o amplia op\u00e7\u00f5es terap\u00eauticas e refor\u00e7a o debate sobre custos e sustentabilidade na sa\u00fade suplementar, em um cen\u00e1rio de alta das doen\u00e7as cr\u00f4nicas e maior uso de terapias da classe GLP-1.<\/p>\n","protected":false},"author":1,"featured_media":21142,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[23],"tags":[9],"class_list":["post-21130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gestao-da-saude","tag-rh"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ozivy: Anvisa aprova semaglutida para tratamento do diabetes<\/title>\n<meta name=\"description\" content=\"Anvisa aprova a Ozivy, semaglutida nacional an\u00e1loga ao Ozempic. Entenda impacto no tratamento do diabetes e na sa\u00fade suplementar.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ozivy: Anvisa aprova semaglutida para tratamento do diabetes\" \/>\n<meta property=\"og:description\" content=\"Anvisa aprova a Ozivy, semaglutida nacional an\u00e1loga ao Ozempic. Entenda impacto no tratamento do diabetes e na sa\u00fade suplementar.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/\" \/>\n<meta property=\"og:site_name\" content=\"Insights \/ Acrisure\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-25T14:40:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T14:46:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/ozivy-aprovacao-anvisa1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1620\" \/>\n\t<meta property=\"og:image:height\" content=\"650\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"publishouse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"publishouse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/\"},\"author\":{\"name\":\"publishouse\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\"},\"headline\":\"Ozivy: Anvisa aprova semaglutida nacional para tratamento do diabetes\",\"datePublished\":\"2026-06-25T14:40:45+00:00\",\"dateModified\":\"2026-06-25T14:46:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/\"},\"wordCount\":549,\"publisher\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/ozivy-aprovacao-anvisa1.jpg\",\"keywords\":[\"RH\"],\"articleSection\":[\"Gest\u00e3o da sa\u00fade\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/\",\"name\":\"Ozivy: Anvisa aprova semaglutida para tratamento do diabetes\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/ozivy-aprovacao-anvisa1.jpg\",\"datePublished\":\"2026-06-25T14:40:45+00:00\",\"dateModified\":\"2026-06-25T14:46:45+00:00\",\"description\":\"Anvisa aprova a Ozivy, semaglutida nacional an\u00e1loga ao Ozempic. Entenda impacto no tratamento do diabetes e na sa\u00fade suplementar.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/ozivy-aprovacao-anvisa1.jpg\",\"contentUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/ozivy-aprovacao-anvisa1.jpg\",\"width\":1620,\"height\":650,\"caption\":\"Old lady is testing blood sugar level using blood sugar test kid set - people with medical equipment concept\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/ozivy-aprovacao-anvisa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ozivy: Anvisa aprova semaglutida nacional para tratamento do diabetes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#website\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\",\"name\":\"Insights \\\/ Acrisure\",\"description\":\"Portal de Not\u00edcias e Conte\u00fado\",\"publisher\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#organization\",\"name\":\"Acrisure Brasil\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/Acrisure_Logo_Vert_Preto_RGB_JPG-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/wp-content\\\/uploads\\\/Acrisure_Logo_Vert_Preto_RGB_JPG-scaled.jpg\",\"width\":2560,\"height\":1829,\"caption\":\"Acrisure Brasil\"},\"image\":{\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/acrisure_br\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/acrisurebrasil\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/#\\\/schema\\\/person\\\/ae285068bde2d94bbb6b0692760fb361\",\"name\":\"publishouse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g\",\"caption\":\"publishouse\"},\"sameAs\":[\"https:\\\/\\\/acrisure.com.br\\\/insights\"],\"url\":\"https:\\\/\\\/acrisure.com.br\\\/insights\\\/author\\\/publishouse\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ozivy: Anvisa aprova semaglutida para tratamento do diabetes","description":"Anvisa aprova a Ozivy, semaglutida nacional an\u00e1loga ao Ozempic. Entenda impacto no tratamento do diabetes e na sa\u00fade suplementar.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/","og_locale":"pt_BR","og_type":"article","og_title":"Ozivy: Anvisa aprova semaglutida para tratamento do diabetes","og_description":"Anvisa aprova a Ozivy, semaglutida nacional an\u00e1loga ao Ozempic. Entenda impacto no tratamento do diabetes e na sa\u00fade suplementar.","og_url":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/","og_site_name":"Insights \/ Acrisure","article_published_time":"2026-06-25T14:40:45+00:00","article_modified_time":"2026-06-25T14:46:45+00:00","og_image":[{"width":1620,"height":650,"url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/ozivy-aprovacao-anvisa1.jpg","type":"image\/jpeg"}],"author":"publishouse","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"publishouse","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#article","isPartOf":{"@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/"},"author":{"name":"publishouse","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361"},"headline":"Ozivy: Anvisa aprova semaglutida nacional para tratamento do diabetes","datePublished":"2026-06-25T14:40:45+00:00","dateModified":"2026-06-25T14:46:45+00:00","mainEntityOfPage":{"@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/"},"wordCount":549,"publisher":{"@id":"https:\/\/acrisure.com.br\/insights\/#organization"},"image":{"@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/ozivy-aprovacao-anvisa1.jpg","keywords":["RH"],"articleSection":["Gest\u00e3o da sa\u00fade"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/","url":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/","name":"Ozivy: Anvisa aprova semaglutida para tratamento do diabetes","isPartOf":{"@id":"https:\/\/acrisure.com.br\/insights\/#website"},"primaryImageOfPage":{"@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#primaryimage"},"image":{"@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#primaryimage"},"thumbnailUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/ozivy-aprovacao-anvisa1.jpg","datePublished":"2026-06-25T14:40:45+00:00","dateModified":"2026-06-25T14:46:45+00:00","description":"Anvisa aprova a Ozivy, semaglutida nacional an\u00e1loga ao Ozempic. Entenda impacto no tratamento do diabetes e na sa\u00fade suplementar.","breadcrumb":{"@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#primaryimage","url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/ozivy-aprovacao-anvisa1.jpg","contentUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/ozivy-aprovacao-anvisa1.jpg","width":1620,"height":650,"caption":"Old lady is testing blood sugar level using blood sugar test kid set - people with medical equipment concept"},{"@type":"BreadcrumbList","@id":"https:\/\/acrisure.com.br\/insights\/ozivy-aprovacao-anvisa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/acrisure.com.br\/insights\/"},{"@type":"ListItem","position":2,"name":"Ozivy: Anvisa aprova semaglutida nacional para tratamento do diabetes"}]},{"@type":"WebSite","@id":"https:\/\/acrisure.com.br\/insights\/#website","url":"https:\/\/acrisure.com.br\/insights\/","name":"Insights \/ Acrisure","description":"Portal de Not\u00edcias e Conte\u00fado","publisher":{"@id":"https:\/\/acrisure.com.br\/insights\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/acrisure.com.br\/insights\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/acrisure.com.br\/insights\/#organization","name":"Acrisure Brasil","url":"https:\/\/acrisure.com.br\/insights\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/logo\/image\/","url":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/Acrisure_Logo_Vert_Preto_RGB_JPG-scaled.jpg","contentUrl":"https:\/\/acrisure.com.br\/insights\/wp-content\/uploads\/Acrisure_Logo_Vert_Preto_RGB_JPG-scaled.jpg","width":2560,"height":1829,"caption":"Acrisure Brasil"},"image":{"@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/acrisure_br\/","https:\/\/www.linkedin.com\/company\/acrisurebrasil"]},{"@type":"Person","@id":"https:\/\/acrisure.com.br\/insights\/#\/schema\/person\/ae285068bde2d94bbb6b0692760fb361","name":"publishouse","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/28cbb1595e2bba31bae82123e62ffe5e807440c64f2e05ed85a7bd654289e026?s=96&d=mm&r=g","caption":"publishouse"},"sameAs":["https:\/\/acrisure.com.br\/insights"],"url":"https:\/\/acrisure.com.br\/insights\/author\/publishouse\/"}]}},"_links":{"self":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/21130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/comments?post=21130"}],"version-history":[{"count":5,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/21130\/revisions"}],"predecessor-version":[{"id":21143,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/posts\/21130\/revisions\/21143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/media\/21142"}],"wp:attachment":[{"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/media?parent=21130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/categories?post=21130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/acrisure.com.br\/insights\/wp-json\/wp\/v2\/tags?post=21130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}